Further/RB study/NN of/IN a/DT newly/RB isolated/VBN hormone/NN found/VBD in/IN the/DT pancreases/NNS of/IN diabetics/NNS may/MD lead/VB to/TO new/JJ treatments/NNS for/IN the/DT most/RBS common/JJ form/NN of/IN the/DT disease/NN ,/, a/DT scientist/NN says/VBZ ./. ``/`` We/PRP have/VBP a/DT lot/NN of/IN evidence/NN that/IN this/DT is/VBZ likely/JJ to/TO be/VB ,/, if/IN not/RB the/DT final/JJ cause/NN ,/, at/IN least/JJS a/DT major/JJ part/NN of/IN the/DT disease/NN process/NN ,/, ''/'' said/VBD New/NNP Zealand/NNP biochemist/NN Garth/NNP Cooper/NNP ./. The/DT research/NN ``/`` opens/VBZ the/DT door/NN to/TO the/DT scientific/JJ study/NN of/IN the/DT disease/NN at/IN a/DT level/NN that/IN was/VBD n't/RB possible/JJ before/IN and/CC potentially/RB the/DT mechanisms/NNS that/IN we/PRP uncover/VBP may/MD be/VB very/RB wide/JJ ranging/VBG ,/, ''/'' he/PRP said/VBD ./. Cooper/NNP ,/, who/WP has/VBZ been/VBN working/VBG with/IN scientists/NNS at/IN Oxford/NNP University/NNP ,/, described/VBD the/DT hormone/NN research/NN this/DT week/NN at/IN the/DT 13th/NN International/NNP Diabetes/NNP Federation/NNP Congress/NNP in/IN Sydney/NNP ,/, Australia/NNP ./. In/IN his/PRP$ presentation/NN ,/, Cooper/NNP said/VBD the/DT hormone/NN ,/, dubbed/VBN ``/`` amylin/NN ,/, ''/'' was/VBD normally/RB undetectable/JJ but/CC found/VBN in/IN high/JJ levels/NNS in/IN the/DT pancreases/NNS of/IN diabetics/NNS ./. Amylin/NNP appears/VBZ to/TO be/VB responsible/JJ for/IN the/DT obesity/NN ,/, reduced/VBN insulin/NN secretion/NN and/CC the/DT reduced/VBN effectiveness/NN of/IN insulin/NN observed/VBN in/IN Type/NN II/NNP diabetes/NN ,/, he/PRP said/VBD ./. Currently/RB ,/, obesity/NN is/VBZ considered/VBN a/DT major/JJ contributor/NN to/TO the/DT disease/NN rather/RB than/IN a/DT result/NN of/IN it/PRP ./. Insulin/NN normally/RB controls/VBZ the/DT level/NN of/IN blood/NN sugar/NN ./. In/IN Type/NNP II/NNP diabetes/NN ,/, also/RB called/VBN non-insulin-dependent/JJ diabetes/NN ,/, the/DT body/NN 's/POS insulin/NN is/VBZ not/RB effective/JJ and/CC blood/NN sugar/NN levels/NNS rise/VBP too/RB high/JJ ./. Complications/NNS can/MD include/VB kidney/NN disease/NN ,/, blindness/NN ,/, and/CC gangrene/NN that/IN requires/VBZ amputations/NNS ./. Type/NNP II/NNP diabetes/NN afflicts/VBZ the/DT majority/NN of/IN the/DT nation/NN 's/POS estimated/VBN 11/CD million/CD diabetics/NNS ,/, according/VBG to/TO the/DT American/JJ Diabetes/NNP Association/NNP ./. It/PRP often/RB can/MD be/VB controlled/VBN through/IN diet/NN and/CC exercise/NN ./. Cooper/NNP said/VBD researchers/NNS hope/VBP to/TO develop/VB substances/NNS that/IN block/NN amylin/NN 's/POS secretion/NN or/CC action/NN ,/, opening/VBG the/DT possibility/NN of/IN treatment/NN ./. He/PRP also/RB said/VBD reseachers/NNS hope/VBP to/TO develop/VB a/DT test/NN to/TO detect/VB diabetes/NN very/RB early/RB in/IN its/PRP$ development/NN ./. The/DT new/JJ work/NN is/VBZ ``/`` a/DT very/RB important/JJ finding/NN ''/'' if/IN amylin/NN truly/RB blocks/NNS insulin/NN and/CC appears/VBZ in/IN abnormal/JJ amounts/NNS in/IN diabetics/NNS ,/, F./NNP Xavier/NNP Pi-Sunyer/NNP ,/, an/DT authority/NN on/IN Type/NNP II/NNP diabetes/NN ,/, said/VBD Friday/NNP ./. Scientists/NNS already/RB knew/VBD of/IN another/DT pancreatic/JJ hormone/NN that/IN blocks/NNS insulin/NN ,/, but/CC it/PRP is/VBZ not/RB found/VBN in/IN abnormal/JJ levels/NNS in/IN diabetics/NNS ,/, said/VBD Pi-Sunyer/NNP ,/, director/NN of/IN the/DT endocrinology/NN ,/, diabetes/NN and/CC nutrition/NN division/NN at/IN St./NNP Luke/NNP 's/POS -/: Roosevelt/NNP Hospital/NNP Center/NNP in/IN New/NNP York/NNP ./. 